WLKP — Westlake Chemical Partners LP

Summary of Westlake Chemical Partners Q4 2025 Earnings Call

1. Key Financial Results and Metrics

• Q4 2025 Results:
  • Net income: $15 million ($0.41 per unit)
  • Consolidated net income (including OpCo): $84 million
  • Consolidated net sales: $323 million
  • Distributable cash flow: $19 million ($0.53 per unit), up from $15 million in Q4 2024
• Full Year 2025 Results:
  • Net income: $49 million ($1.38 per unit), down from $62 million in 2024
  • MLP distributable cash flow: $53 million, down from $67 million in 2024
  • Distribution coverage ratio: 0.8x for 2025
• Cash Position: Consolidated cash and investments totaled $68 million; long-term debt stood at $400 million.

2. Strategic Updates and Business Highlights

• The partnership benefits from a fixed margin ethylene sales agreement covering 95% of annual production, providing stability against market volatility.
• Successfully renewed the ethylene sales agreement with Westlake through 2027 without changes, underscoring the importance of OpCo’s ethylene supply.
• Achieved 46 consecutive quarterly distributions since the IPO in July 2014, with a 71% increase in distributions since the original minimum quarterly distribution.

3. Forward Guidance and Outlook

• No planned turnarounds in 2026, which is expected to improve production and sales volumes, leading to a recovery in distributable cash flow and coverage ratio back to historical levels.
• Anticipated increase in coverage ratio above 1.1x in 2026 due to the absence of turnaround costs and a strong operating surplus.

4. Bad News, Challenges, or Points of Concern

• Full-year net income decreased by $13 million compared to 2024, primarily due to lower production and sales volumes linked to the planned turnaround at the Petro 1 facility.
• The distribution coverage ratio fell below 1x during 2025, which is a concern for maintaining sustainable distributions.
• Potential reliance on drawing down investment management accounts to cover distributions during turnaround years raises questions about long-term cash flow stability.

5. Notable Q&A Insights

• Management clarified that the drawdown on the investment management agreement was due to turnaround expenses, and they expect to replenish cash balances in 2026 with no planned turnarounds.
• Future growth initiatives, such as increasing ownership interest in OpCo or pursuing acquisitions, would likely be financed through a combination of debt, equity, or monetizing portions of OpCo interest.
• The management emphasized their commitment to maintaining a strong balance sheet and conservative financial metrics while exploring growth opportunities.

This summary encapsulates the key financial metrics, strategic updates, forward guidance, challenges, and insights from the Q&A session, providing a comprehensive overview of Westlake Chemical Partners' performance and outlook.